The role of endoscopic biliary stents in palliative care

Palliative Medicine

Volumn 13, Issue 1, 1999, Pages 63-68

  Roth, L J ^a,b   Pugh, E J ^a  

^a Butterwick Hospice   (United Kingdom)

^b Palliative Medicine   (United Kingdom)

Author keywords

Endoscopic retrograde cholangiopancreatography; Jaundice; Palliative care; Stents

Indexed keywords

ANABOLIC AGENT; CEPHALOSPORIN; COLESTYRAMINE; NALOXONE; ONDANSETRON; RIFAMPICIN;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; CASE REPORT; CHOLANGITIS; ENDOSCOPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; PALLIATIVE THERAPY; PRURITUS; STENT; TREATMENT INDICATION;

AGED; BILE DUCT NEOPLASMS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLESTASIS; FEMALE; HUMANS; MIDDLE AGED; PALLIATIVE CARE; STENTS;

EID: 0032988589     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/026921699670064030     Document Type: Article

References (24)

1. Davies MG, Marks R, Horton RJ, Storari FE. The efficacy of histamine antagonists as antipruritics in experimentally induced pruritus. Arch Derm Res 1979; 266: 117-20.
2. Walt RP, Daneshmend TK, Fellows IW, Toghill PJ. Effect of stanozolol on itching in primary biliary cirrhosis. Br Med J 1988; 296: 607.
3. Cynamon HA, Andres JM, Iafrate RP. Rifampicin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990; 98: 1013-16.
4. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampicin. Results of a double-blind crossover randomized trial. Gastroenterology 1988; 94: 488-93.
5. Raderer M, Müller C, Scheithauer W. Ondansetron for pruritus due to cholestasis. N Engl J Med 1994; 330: 1540.
6. Bergasa NV, Talbot TL, Ailing DW et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992; 102: 544-49.
7. Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. J Am Med Assoc 1992; 268: 3359-62.
8. Shepherd HA, Royle G, Ross APR, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988; 75: 1166-68.
9. Andersen JR, Sørensen SM, Kruse A, Rokkjær M, Matzen P. Randomized trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989; 30: 1132-35.
10. Smith AC, Dowsett JF, Russell RCG, Hatfield ARW, Cotton PB. Randomized trial of endoscopie stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 334: 1655-60.
11. Watanapa P, Williamson RCN. Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 1992; 79: 8-20.
12. Speer AG, Russell RCG, Hatfield ARW et al. Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; ii: 57-62.
13. Cotton PB. Nonsurgical palliation of jaundice in pancreatic cancer. Surg Clin North Am 1989; 69: 613-27.
14. McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of Vater; a preliminary report. Ann Surg 1968; 167: 752-56.
15. Dowsett JF, Vaira D, Polydorou A, Russell RO, Salmon PR. Interventional endoscopy in the pancreatobiliary tree. Am J Gastroenterology 1988; 83: 1328-36.
16. Tytgat GNJ, Bartelsman JFWM, Den Hartog Jager FCA, Huibregtse K, Mathus-Vliegen EMH. Upper intestinal and biliary tract endoprosthesis. Dig Dis Sci 1986; 31: 57S-76S.
17. Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopie internal biliary drainage. Gastrointest Endosc 1988; 34: 95-101.
18. Jaffe BM, Donegan WL, Watson F, Spratt JS. Factors influencing survival in patients with untreated hepatic metastases. Surg Gyn Obst 1968; 127: 1-11.
19. Siegel JH, Snady H. The significance of endoscopically placed prostheses in the management of biliary obstruction due to carcinoma in the pancreas: results of nonoperative decompression in 277 patients. Am J Gastroenterology 1986; 81: 634-41.
20. Speer AG, Cotton PB, MacRae KD. Endoscopic management of malignant biliary obstruction: stents of 10F gauge are preferable to stents of 8F gauge. Gastrointest Endosc 1988; 34: 412-17.
21. Siegel JH, Pullano W, Kodsi B, Cooperman A, Ramsey W. Optimal palliation of malignant bile duct obstruction: experience with endoscopic 12F prostheses. Endoscopy 1988; 20: 137-41.
22. Nicholson AA, Royston CMS. Palliation of inoperable biliary obstruction with self-expanding metal endoprostheses: a review of 77 patients. Clin Radiol 1993; 47: 245-50.
23. Huibregtse K, Carr-Locke D, Cremer M et al. Experience with an endoscopically inserted expandable biliary metal stent (Wallstent). Gastroenterology 1990; 98: A287.
24. Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K. Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488-92.